Glenmark gets USFDA nod for generic Derma-Smoothe Topical Oil Medical Dialogues Bureau31 Oct 2018 5:16 PM ISTNew Delhi: Glenmark Pharmaceuticals Tuesday said it has received final approval from the US health regulator for the generic version of Derma-Smoothe...
Pfizer lowers revenue forecast on strong dollar, supply issues Medical Dialogues Bureau31 Oct 2018 5:15 PM ISTU.S. drugmaker Pfizer Inc cut the top end of its full-year revenue forecast range on Tuesday, citing a stronger dollar and lower revenue from its...
AstraZeneca sells some rights to Nexium, Vimovo to Grunenthal Medical Dialogues Bureau31 Oct 2018 5:15 PM ISTLONDON: AstraZeneca said it would sell the European rights to acid-reflux medicine Nexium to Grunenthal for an upfront $700 million and future...
Monsanto India Q2 profit at Rs 24 cr, revenue up 33% at Rs 133.49 cr Medical Dialogues Bureau31 Oct 2018 5:14 PM ISTNew Delhi: Seed firm Monsanto India Monday reported a net profit of Rs 24.09 crore for the quarter ended September 2018. Its net loss stood at Rs 6.39...
Eli Lilly buys Rs 736 Crore stake in gene-silencing drug firm Dicerna Medical Dialogues Bureau30 Oct 2018 4:43 PM ISTDicerna will receive an upfront payment of $100 million, as well as an equity investment of $100 million at a premium. New Delhi: Eli Lilly and...
Granules gets 2 observation by USFDA for U.S Unit Medical Dialogues Bureau30 Oct 2018 10:48 AM ISTNew Delhi: Pharma firm Granules through a recent regulatory filing announced its US subsidiary has received two observations from the US health...
Cipla gets USFDA approval for Metoprolol ER Tablets Medical Dialogues Bureau30 Oct 2018 9:25 AM ISTMumbai: Cipla Limited announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Metoprolol ER Tablets 50mg,...
TherapeuticsMD gets FDA approval of Bijuva drug Medical Dialogues Bureau30 Oct 2018 9:20 AM ISTNew Delhi: TherapeuticsMD, Inc. an innovative women’s healthcare company, has recently announced that the United States Food and Drug Administration...
Takeda proposes sale of Shire drug to gain European approval Medical Dialogues Bureau30 Oct 2018 9:00 AM ISTNew Delhi: Takeda Pharmaceutical has proposed to European regulators it could sell a Shire treatment in development due to concerns of overlap in...
New USFDA Generic Guidelines to help Indian Pharma Companies in Submitting ANDAs Medical Dialogues Bureau29 Oct 2018 4:23 PM ISTNew Delhi: A weekend report by India Ratings has declared that the recent guidance from the US Food & Drug Administration (USFDA) on complex...
Cipla gets USFDA approval for Hypertension, Cardiac drug Medical Dialogues Bureau29 Oct 2018 10:00 AM ISTNEW DELHI: Pharmaceutical giant Cipla has recently announced that it has received final approval from the US health regulator to market Metoprolol...
Big Pharma Companies to Return to Double-Digit Growth this Fiscal: Crisil Medical Dialogues Bureau29 Oct 2018 9:45 AM ISTDomestic revenues of big pharma companies are expected to grow 12-13 per cent this fiscal, given better access to healthcare and deeper penetration of...
